SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013762-21-000181
Filing Date
2021-10-05
Accepted
2021-10-04 21:59:23
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_bostonthera.htm   iXBRL 10-Q 654269
2 CERTIFICATION f10q0621ex31-1_boston.htm EX-31.1 15195
3 CERTIFICATION f10q0621ex31-2_boston.htm EX-31.2 11332
4 CERTIFICATION f10q0621ex32-1_boston.htm EX-32.1 4497
5 CERTIFICATION f10q0621ex32-2_boston.htm EX-32.2 4406
  Complete submission text file 0001013762-21-000181.txt   4751751

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bthe-20210630.xsd EX-101.SCH 65411
7 XBRL CALCULATION FILE bthe-20210630_cal.xml EX-101.CAL 33314
8 XBRL DEFINITION FILE bthe-20210630_def.xml EX-101.DEF 259924
9 XBRL LABEL FILE bthe-20210630_lab.xml EX-101.LAB 519210
10 XBRL PRESENTATION FILE bthe-20210630_pre.xml EX-101.PRE 272153
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_bostonthera_htm.xml XML 512612
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 211305052
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences